| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/10/2023 | 85.33% | B. Riley Securities | $27 → $24 | Maintains | Buy |
| 07/18/2023 | 93.05% | Truist Securities | $27 → $25 | Maintains | Buy |
| 05/11/2023 | 93.05% | Raymond James | $26 → $25 | Maintains | Strong Buy |
| 05/02/2023 | 85.33% | Stifel | $25 → $24 | Maintains | Buy |
| 01/17/2023 | 93.05% | Craig-Hallum | $30 → $25 | Maintains | Buy |
| 08/04/2022 | 100.77% | Raymond James | $23 → $26 | Maintains | Strong Buy |
| 07/20/2022 | 131.66% | Truist Securities | $32 → $30 | Maintains | Buy |
| 06/28/2022 | 170.27% | B. Riley Securities | $36 → $35 | Maintains | Buy |
| 05/11/2022 | 77.61% | Raymond James | $30 → $23 | Maintains | Strong Buy |
| 01/11/2022 | 131.66% | Raymond James | $33 → $30 | Maintains | Strong Buy |
| 11/04/2021 | 154.83% | Raymond James | $28 → $33 | Maintains | Strong Buy |
| 05/06/2021 | 77.61% | Raymond James | $19 → $23 | Maintains | Strong Buy |
| 04/28/2021 | 93.05% | B. Riley Securities | → $25 | Initiates Coverage On | → Buy |
| 01/14/2021 | 46.72% | Raymond James | $13 → $19 | Maintains | Strong Buy |
| 12/03/2020 | 62.16% | Roth Capital | $20 → $21 | Maintains | Buy |
| 11/03/2020 | 0.39% | Raymond James | $10 → $13 | Maintains | Strong Buy |
| 10/13/2020 | 39% | Roth Capital | $17 → $18 | Maintains | Buy |
| 09/09/2020 | -7.34% | BTIG | → $12 | Initiates Coverage On | → Buy |
| 07/10/2020 | 31.27% | Roth Capital | → $17 | Initiates Coverage On | → Buy |
| 06/03/2020 | -38.22% | SunTrust Robinson Humphrey | $6 → $8 | Maintains | Buy |
| 06/03/2020 | -22.78% | Raymond James | $14 → $10 | Maintains | Strong Buy |
| 05/28/2020 | -30.5% | Stifel | $6 → $9 | Maintains | Buy |
| 05/06/2020 | -53.67% | SunTrust Robinson Humphrey | $16 → $6 | Maintains | Buy |
| 11/18/2019 | 15.83% | Raymond James | $14 → $15 | Reiterates | → Strong Buy |
| 09/26/2019 | -7.34% | Macquarie | → $12 | Initiates Coverage On | → Outperform |
| 02/11/2019 | — | SunTrust Robinson Humphrey | Initiates Coverage On | → Buy | |
| 09/13/2018 | 0.39% | Stifel | → $13 | Reinstates | → Buy |
What is the target price for Everi Hldgs (EVRI)?
The latest price target for Everi Hldgs (NYSE: EVRI) was reported by B. Riley Securities on August 10, 2023. The analyst firm set a price target for $24.00 expecting EVRI to rise to within 12 months (a possible 85.33% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Everi Hldgs (EVRI)?
The latest analyst rating for Everi Hldgs (NYSE: EVRI) was provided by B. Riley Securities, and Everi Hldgs maintained their buy rating.
When is the next analyst rating going to be posted or updated for Everi Hldgs (EVRI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Everi Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Everi Hldgs was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
Is the Analyst Rating Everi Hldgs (EVRI) correct?
While ratings are subjective and will change, the latest Everi Hldgs (EVRI) rating was a maintained with a price target of $27.00 to $24.00. The current price Everi Hldgs (EVRI) is trading at is $12.95, which is out of the analyst's predicted range.